soul trial oral semaglutide cardiovascular outcomes nejm 2024 2025 Reduces CV Events in T2DM – (NEJM, Mar 2025) Relevant for: cardiology, diabetology, nephrology, internal medicine 🧪 T2DM + ASCVD/CKD 💊 Oral semaglutide 14 mg vs placebo 📉 SOUL Trial Shows Oral Semaglutide

Th nhng, vic chm da trng mn li khng h d dng

That means that 1 in 100 people using oral contraceptives will get pregnant each year even if they take their pill religiously at the same time every day

They affect approximately 1 in 10 people in the UK at some point in their lives, with men being more commonly affected than women

The decision about which weight loss option is appropriate should always be made in partnership with your doctor, who will consider several important factors, including: Your overall health Medical history Current medications The amount of weight youre aiming to lose Your tolerance for certain treatments Always talk with your doctor when exploring effective weight loss options

The patient portal carried no tracking information at all